Opening Hodgkin Lymphoma - Dr. Ferry (MGH) #HEMEPATH
Hodgkin Lymphoma - Dr. Ferry (MGH) #HEMEPATH
- Length
- 1 h 4 min
- Level
- Undergraduate
- Recorded
- pathCast2019 · Standalone Lecture
Chapter 1 of 10: Before the lecture
Ferry contrasts LP and Reed-Sternberg cells and weighs mimics from CMV lymphadenitis to gray-zone lymphoma.
Hodgkin lymphoma divides into nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma, each with its own cells, immunophenotype and differential diagnosis. Ferry, Director of Hematopathology at Massachusetts General Hospital, begins with CD20- and BCL6-positive LP cells and the six histologic patterns from a Stanford study. She then defines classical Hodgkin lymphoma by CD30- and CD15-positive Reed-Sternberg cells and contrasts its nodular sclerosis, mixed cellularity and lymphocyte-rich subtypes. Primary mediastinal large B-cell lymphoma, gray-zone lymphoma, infectious mononucleosis and Castleman disease serve as diagnostic pitfalls. Familiarity with lymph node architecture and standard immunohistochemical markers is assumed.
Hodgkin lymphoma divides into nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma, each with its own cells, immunophenotype and differential diagnosis. Ferry, Director of Hematopathology at Massachusetts General Hospital, begins with CD20- and BCL6-positive LP cells and the six histologic patterns from a Stanford study. She then defines classical Hodgkin lymphoma by CD30- and CD15-positive Reed-Sternberg cells and contrasts its nodular sclerosis, mixed cellularity and lymphocyte-rich subtypes. Primary mediastinal large B-cell lymphoma, gray-zone lymphoma, infectious mononucleosis and Castleman disease serve as diagnostic pitfalls. Familiarity with lymph node architecture and standard immunohistochemical markers is assumed.
Landmark study from Stanford University
NIH Study
A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma
WHO Classification
Slack G et al, Leuk Lymphoma 2009; 50(6):1-7
WHO classification of tumours of haematopoietic and lymphoid tissues

Your comment is kept while you sign up.Sign in